CRIS Current Research Information System

GATTO, LIDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.096
EU - Europa 1.385
AS - Asia 507
AF - Africa 143
SA - Sud America 7
OC - Oceania 5
Totale 4.143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.085
IT - Italia 382
GB - Regno Unito 265
CN - Cina 218
SE - Svezia 214
SG - Singapore 165
DE - Germania 130
CH - Svizzera 95
IE - Irlanda 81
IN - India 62
CI - Costa d'Avorio 56
TG - Togo 54
FR - Francia 48
RU - Federazione Russa 43
VN - Vietnam 31
FI - Finlandia 22
BG - Bulgaria 21
EE - Estonia 21
ZA - Sudafrica 21
JO - Giordania 13
UA - Ucraina 13
BE - Belgio 10
NG - Nigeria 9
PL - Polonia 8
AT - Austria 7
SK - Slovacchia (Repubblica Slovacca) 6
AU - Australia 5
CA - Canada 5
NL - Olanda 5
HR - Croazia 4
NI - Nicaragua 4
CL - Cile 3
IR - Iran 3
JP - Giappone 3
RO - Romania 3
BR - Brasile 2
EG - Egitto 2
LB - Libano 2
MX - Messico 2
NO - Norvegia 2
TR - Turchia 2
TW - Taiwan 2
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 4.143
Salva come PNG Salva come JPEG
Città #
Chandler 262
Southend 250
Fairfield 244
Ashburn 156
Singapore 146
Houston 99
Woodbridge 98
Bologna 93
Bern 92
Wilmington 91
Princeton 88
Seattle 88
Ann Arbor 84
Dublin 81
Cambridge 68
Redmond 60
Abidjan 56
Lomé 54
Santa Clara 35
New York 34
Berlin 28
Westminster 24
Beijing 22
Helsinki 22
Sofia 21
Nanjing 20
Milan 18
San Diego 16
Turin 16
Padova 15
Amman 13
Jinan 13
Kuban 13
Ravenna 13
Falls Church 12
Shenyang 12
Rome 11
Hyderabad 10
Naples 10
Torino 10
Abeokuta 9
Brussels 9
Zhengzhou 9
Changsha 8
Forlì 8
Bremen 7
Florence 7
Guangzhou 7
Hebei 7
London 7
Norwalk 7
Olalla 7
Saint Petersburg 7
Boydton 6
Hefei 6
Los Angeles 6
Nanchang 6
San Francisco 6
Warsaw 6
Dearborn 5
Jiaxing 5
Kunming 5
Monmouth Junction 5
Redwood City 5
Vienna 5
Žilina 5
Bentivoglio 4
Cesena 4
Chicago 4
Des Moines 4
Hangzhou 4
Managua 4
Montescudo 4
Shanghai 4
Tianjin 4
Toronto 4
Verona 4
Wuhan 4
Andover 3
Ardabil 3
Boardman 3
Canberra 3
Changzhou 3
Dong Ket 3
Fremont 3
Fuzhou 3
Harbin 3
Lanzhou 3
Medford 3
Paris 3
Pescara 3
Phoenix 3
Sacramento 3
Shijiazhuang 3
Taizhou 3
Baotou 2
Bari 2
Boston 2
Bühl 2
Casalgrande 2
Totale 2.777
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 262
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 177
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 156
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 155
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 147
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 143
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 142
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 134
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 129
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 129
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 127
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 122
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 119
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 112
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 110
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 104
Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report 104
null 98
Radiotherapy in the management of gist: state of the art and new potential scenarios 97
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 95
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 95
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 94
SDHA and SDHB mutations in KIT/PDGFRA WT gastrointestinal stromal tumors 90
The human microbiota and prostate cancer: Friend or foe? 90
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 79
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis. 77
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem 73
The clinical and prognostic role of ALK in glioblastoma 68
Optical coherence tomography assessment of macrophages accumulation in non-ST-segment elevation acute coronary syndromes. 66
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study 64
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 61
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review 56
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective study 54
Glioblastoma: Emerging treatments and novel trial designs 54
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer? 54
IDH1105GGT single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomas 51
Discovering the molecular landscape of meningioma: The struggle to find new therapeutic targets 50
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: An unassessed issue 48
Idh1 non-canonical mutations and survival in patients with glioma 45
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment 43
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light 39
Machine learning in neuro-oncology: toward novel development fields 38
Adult Medulloblastoma: Updates on Current Management and Future Perspectives 35
Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 35
Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas 35
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report 29
Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients? 27
Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives. 25
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? 19
Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back? 15
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer 14
Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers 14
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 11
Optimizing renal function and outcome of patients with cT2 renal cell carcinoma 8
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue 6
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 5
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes 3
Totale 4.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020726 0 0 0 41 94 76 128 116 106 78 53 34
2020/2021377 88 31 22 7 7 16 11 39 73 14 21 48
2021/2022855 57 31 19 44 67 37 15 97 46 75 245 122
2022/20231.193 104 153 52 131 77 112 39 73 216 43 59 134
2023/2024387 44 78 26 34 19 76 12 30 7 22 17 22
2024/2025442 101 184 128 29 0 0 0 0 0 0 0 0
Totale 4.332